Parliamentary motion filed over financial burden faced by children with diabetes and their families
1 ޖޫން 2026 | ހޯމަ 10:05He has requested that the senior management of Aasandha Company be summoned before the Parliament's Social Affairs Committee to clarify the matter and explore potential avenues for resolution.
Mohamed Ibrahim (Kudu), Member of Parliament for the North Galolhu constituency. | RaajjeMV
A proposal has been submitted to Parliament seeking to alleviate the financial burden faced by children living with diabetes and their families.
The proposal was submitted by Mohamed Ibrahim, the Member of Parliament for the North Galolhu constituency.
In a letter addressed to the Speaker of Parliament, Abdul Raheem Abdulla, he highlighted that Type 1 diabetes is a condition caused by the destruction of insulin-producing cells in the body, noting that it is currently an unpreventable disease. He further emphasized that the primary treatment involves regular insulin administration, consistent blood sugar monitoring, and maintaining a lifestyle focused on a healthy diet and exercise under the guidance of medical professionals.
Although the doctors on the Type 1 diabetes treatment team are practitioners at government hospitals, patients are often forced to endure long periods on waiting lists for appointments. Since timely access to these specialists is generally only available through private clinics, families are compelled to pay thousands of Rufiyaa out of pocket for every consultation.
The challenges faced by individuals living with diabetes in the city have been highlighted, along with the necessary measures to address them. Key recommendations include expanding Aasandha coverage for blood glucose meters and test strips to all individuals with Type 1 diabetes, regardless of age, rather than limiting the benefit to those under 25.
Furthermore, requests have been made to include Continuous Glucose Monitor (CGM) sensors under the Aasandha national health insurance scheme, and to facilitate the importation and accessibility of insulin pumps and their necessary accessories within the Maldives.
Furthermore, requests were made to ensure a continuous supply of insulin and to facilitate the availability of 4mm needles required for children within the Maldives. He requested that the heads of the Aasandha Company be summoned to the Parliament’s Social Affairs Committee to determine the measures that can be taken regarding these issues.
